CD36 and hepatocellular carcinoma: Small-molecule inhibitors targeting CD36, like Sulfosuccinimidyl oleate (SSO), significantly curtail fatty acid uptake, leading to the inhibition of ovarian cancer cell growth and the reduced migration of hepatocellular carcinoma (HCC) cells [31,32].